Mohammad Reza Rouini (Mohammadreza Rouini)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Molecularly Imprinted

Methicillin Resistant Staphylococcus Aureus

Alcohol Use Disorder

Top Venues

Pharmaceutical development and technology

The Journal of dermatological treatment

Advanced pharmaceutical bulletin

Critical care research and practice

This page only lists publications with an associated author ORCID identifier.

Publications

Maryam Ghareh Sheikhlou, Nazanin Shabani Ravari, Milad Behrouzi, Navid Goodarzi, Roshana Saghafian Larijani, Reyhaneh Varshochian, Rassoul Dinarvand, Mohammad Reza Rouini
Engineered PLGA microspheres for extended-release of naltrexone: in vitro, in vivo , and IVIVR. Pharmaceutical development and technology 28 (2) (2023)
Maryam Ghareh Sheikhlou, Nazanin Shabani Ravari, Milad Behrouzi, Navid Goodarzi, Roshana Saghafian Larijani, Reyhaneh Varshochian, Rassoul Dinarvand, Mohammad Reza Rouini
Engineered PLGA microspheres for extended-release of naltrexone: in vitro, in vivo , and IVIVR. Pharmaceutical development and technology 28 (2) (2023)
Maryam Ghareh Sheikhlou, Nazanin Shabani Ravari, Milad Behrouzi, Navid Goodarzi, Roshana Saghafian Larijani, Reyhaneh Varshochian, Rassoul Dinarvand, Mohammad Reza Rouini
Engineered PLGA microspheres for extended-release of naltrexone: in vitro, in vivo , and IVIVR. Pharmaceutical development and technology (2023)
Maryam Ghareh Sheikhlou, Nazanin Shabani Ravari, Milad Behrouzi, Navid Goodarzi, Roshana Saghafian Larijani, Reyhaneh Varshochian, Rassoul Dinarvand, Mohammad Reza Rouini
Engineered PLGA Microspheres for Extended-release of Naltrexone: In vitro, In vivo , and IVIVR. Pharmaceutical development and technology (2023)
Maryam Ghareh Sheikhlou, Nazanin Shabani Ravari, Milad Behrouzi, Navid Goodarzi, Roshana Saghafian Larijani, Reyhaneh Varshochian, Rassoul Dinarvand, Mohammad Reza Rouini
Engineered PLGA microspheres for extended-release of naltrexone: in vitro, in vivo , and IVIVR. Pharmaceutical development and technology 28 (2) (2023)
Atefeh Naeimifar, Saman Ahmad Nasrollahi, Ansieh Samadi, Zeinab Aryanian, Hamid Akbari Javar, Mohammad Reza Rouini, Mansour Nassiri Kashani, Alireza Firooz
Evaluation of tolerability and efficacy of a topical emulgel containing nanoliposomal ruxolitinib phosphate in the treatment of mild atopic dermatitis: a before-after single group pilot study. The Journal of dermatological treatment (2022)
Sara Bahrainian, Mohammad Reza Rouini, Kambiz Gilani
Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery. Pharmaceutical development and technology 26 (6) (2021)
Bita Shahrami, Farhad Najmeddin, Saeideh Ghaffari, Atabak Najafi, Mohammad Reza Rouini, Mojtaba Mojtahedzadeh
Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement. Critical care research and practice 2020 (2020)
Bita Shahrami, Farhad Najmeddin, Mohammad Reza Rouini, Atabak Najafi, Kourosh Sadeghi, Shahideh Amini, Seyedeh Sana Khezrnia, Hamid Reza Sharifnia, Mojtaba Mojtahedzadeh
Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis. Advanced pharmaceutical bulletin 10 (1) (2019)